4//SEC Filing
MOORE ALISON 4
Accession 0001214659-22-004083
CIK 0001737287other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:58 PM ET
Size
5.8 KB
Accession
0001214659-22-004083
Insider Transaction Report
Form 4
MOORE ALISON
Chief Technical Officer
Transactions
- Sale
Common Stock
2022-03-15$7.63/sh−8,698$66,388→ 120,430 total
Footnotes (3)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Includes 1688 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754937
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:58 PM ET
- Size
- 5.8 KB